Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Randomized Controlled Trial of Local Delivery of a Rho Inhibitor (VX-210) in Patients with Acute Traumatic Cervical Spinal Cord Injury
Michael G. Fehlings, Yang Chen, Bizhan Aarabi, et al.
Journal of Neurotrauma (2021) Vol. 38, Iss. 15, pp. 2065-2072
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Immune response following traumatic spinal cord injury: Pathophysiology and therapies
Robert C. Sterner, Rosalie M. Sterner
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 94
RhoA drives actin compaction to restrict axon regeneration and astrocyte reactivity after CNS injury
Sina Stern, Brett J. Hilton, Emily R. Burnside, et al.
Neuron (2021) Vol. 109, Iss. 21, pp. 3436-3455.e9
Open Access | Times Cited: 98
Pathophysiology, Classification and Comorbidities after Traumatic Spinal Cord Injury
James D. Guest, Nilanjana Datta, George Jimsheleishvili, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 7, pp. 1126-1126
Open Access | Times Cited: 56
An updated systematic review of neuroprotective agents in the treatment of spinal cord injury
Ibrahim Serag, Mohamed Abouzid, Ahmed Elmoghazy, et al.
Neurosurgical Review (2024) Vol. 47, Iss. 1
Closed Access | Times Cited: 11
A review of emerging neuroprotective and neuroregenerative therapies in traumatic spinal cord injury
Nader Hejrati, Michael G. Fehlings
Current Opinion in Pharmacology (2021) Vol. 60, pp. 331-340
Closed Access | Times Cited: 43
Molecular approaches for spinal cord injury treatment
AnaMaria Blanco Martinez, FernandaMartins de Almeida, Suelen Adriani Marques, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 1, pp. 23-23
Open Access | Times Cited: 26
Mechanisms of Axon Growth and Regeneration: Moving between Development and Disease
Frank Bradke
Journal of Neuroscience (2022) Vol. 42, Iss. 45, pp. 8393-8405
Open Access | Times Cited: 26
Axonal growth inhibitors and their receptors in spinal cord injury: from biology to clinical translation
Sílvia Sousa Chambel, Célia Duarte Cruz
Neural Regeneration Research (2023) Vol. 18, Iss. 12, pp. 2573-2581
Open Access | Times Cited: 13
Methylprednisolone substituted lipid nanoparticles deliver C3 transferase mRNA for combined treatment of spinal cord injury
Haoru Dong, Zongxing He, Shiyi Cai, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Axon regeneration after spinal cord and brain injuries
Madeline Rose McCrea, Shuxin Li
Elsevier eBooks (2025), pp. 315-346
Closed Access
KHSRP-mediated Decay of Axonally Localized Prenyl-Cdc42 mRNA Slows Nerve Regeneration
Matthew D. Zdradzinski, Lauren S. Vaughn, Samaneh Matoo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
The potential role of RhoA/ROCK-inhibition on locomotor recovery after spinal cord injury: a systematic review of in-vivo studies
Armin Khavandegar, Negar Ahmadi, Maryam Mousavi, et al.
Spinal Cord (2025)
Closed Access
Therapeutic strategies that modulate the acute phase of secondary spinal cord injury scarring and inflammation and improve injury outcomes
Filippo Migliorini, Marco Pilone, Jörg Eschweiler, et al.
Expert Review of Neurotherapeutics (2025), pp. 1-14
Closed Access
Current and Emergent Therapies Targeting Spinal Cord Injury
Giovanni Grasso, Luigi Maria Cusimano, Manfredi Noto, et al.
Brain and Spine (2025), pp. 104243-104243
Open Access
Personalized Stem Cell-Based Regeneration in Spinal Cord Injury Care
Sasi Kumar Jagadeesan, Ryan Sandarage, Sathya Mathiyalagan, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3874-3874
Open Access
Management of Acute Spinal Cord Injury: Where Have We Been? Where Are We Now? Where Are We Going?
Michael G. Fehlings, Karlo M. Pedro, Nader Hejrati
Journal of Neurotrauma (2022) Vol. 39, Iss. 23-24, pp. 1591-1602
Closed Access | Times Cited: 16
Advancements in neuroregenerative and neuroprotective therapies for traumatic spinal cord injury
Gregor Fischer, Linda Bättig, Martin N. Stienen, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 3
A critical appraisal of clinical practice guidelines on pharmacological treatments for spinal cord injury
Bin Guan, Yuxuan Fan, Ruiyuan Zheng, et al.
The Spine Journal (2022) Vol. 23, Iss. 3, pp. 392-402
Closed Access | Times Cited: 15
Traumatic Human Spinal Cord Injury: Are Single Treatments Enough to Solve the Problem?
Israel Grijalva, Ernesto Doncel‐Pérez
Archives of Medical Research (2023) Vol. 55, Iss. 1, pp. 102935-102935
Closed Access | Times Cited: 8
Pharmacological management of secondary spinal cord injury
Alice Baroncini, Nicola Maffulli, Jörg Eschweiler, et al.
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 13, pp. 1793-1800
Closed Access | Times Cited: 18
Delayed administration of elezanumab, a human anti-RGMa neutralizing monoclonal antibody, promotes recovery following cervical spinal cord injury
Andrea J. Mothe, Peer B. Jacobson, Mitchell T. Caprelli, et al.
Neurobiology of Disease (2022) Vol. 172, pp. 105812-105812
Open Access | Times Cited: 13
Neuromodulation to guide circuit reorganization with regenerative therapies in upper extremity rehabilitation following cervical spinal cord injury
Gustavo Balbinot
Frontiers in Rehabilitation Sciences (2024) Vol. 4
Open Access | Times Cited: 2
Translational Relevance of Secondary Intracellular Signaling Cascades Following Traumatic Spinal Cord Injury
Mohammad-Masoud Zavvarian, Akshat D. Modi, Sarah Sadat, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5708-5708
Open Access | Times Cited: 2
Research advances in stem cell transplantation combined with fibrin scaffold for treating spinal cord injury in an aging society
Tianqi Jiang, Zhijun Chen, Yitong Luo, et al.
Aging Pathobiology and Therapeutics (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 2
Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA2), UCM-14216, Ameliorates Spinal Cord Injury in Mice
Nora Khiar‐Fernández, Debora Zian, Henar Vázquez‐Villa, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 16, pp. 10956-10974
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top